A
Adithya Cattamanchi
Researcher at University of California, San Francisco
Publications - 220
Citations - 7427
Adithya Cattamanchi is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Tuberculosis & Medicine. The author has an hindex of 38, co-authored 187 publications receiving 5788 citations. Previous affiliations of Adithya Cattamanchi include University of San Francisco & Makerere University.
Papers
More filters
Journal ArticleDOI
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.
Payam Nahid,Susan E. Dorman,Narges Alipanah,Pennan M. Barry,Jan Brozek,Adithya Cattamanchi,Lelia H. Chaisson,Richard E. Chaisson,Charles L. Daley,M. Grzemska,Julie Higashi,Christine S Ho,Philip C. Hopewell,Salmaan Keshavjee,Christian Lienhardt,Richard Menzies,Cynthia Merrifield,Masahiro Narita,Rick O'Brien,Charles A. Peloquin,Ann Raftery,Jussi J. Saukkonen,H. Simon Schaaf,Giovanni Sotgiu,Jeffrey R. Starke,Giovanni Battista Migliori,Andrew Vernon +26 more
TL;DR: This guideline provides recommendations on the clinical and public health management of tuberculosis in children and adults in settings in which mycobacterial cultures, molecular and phenotypic drug susceptibility tests, and radiographic studies, among other diagnostic tools, are available on a routine basis.
Journal ArticleDOI
Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection
Madhukar Pai,Claudia M. Denkinger,Claudia M. Denkinger,Sandra V. Kik,Molebogeng X. Rangaka,Alice Zwerling,Olivia Oxlade,John Z. Metcalfe,Adithya Cattamanchi,David W. Dowdy,Keertan Dheda,Niaz Banaei +11 more
TL;DR: To maximize the positive predictive value of existing tests, LTBI screening should be reserved for those who are at sufficiently high risk of progressing to disease and basic research is necessary to identify highly predictive biomarkers.
Journal ArticleDOI
Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis.
Adithya Cattamanchi,Rachel M. Smith,Karen R Steingart,John Z. Metcalfe,Anand Date,Courtney Coleman,Barbara J. Marston,Laurence Huang,Philip C. Hopewell,Madhukar Pai +9 more
TL;DR: Current evidence suggests that IGRAs perform similarly to the tuberculin skin test at identifying HIV-infected individuals with latent tuberculosis infection, given that both tests have modest predictive value and suboptimal sensitivity.
Journal ArticleDOI
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
Payam Nahid,Sundari Mase,Giovanni Battista Migliori,Giovanni Sotgiu,Graham H. Bothamley,Jan Brozek,Adithya Cattamanchi,J. Peter Cegielski,Lisa Chen,Charles L. Daley,Tracy Dalton,Raquel Duarte,Federica Fregonese,C. Robert Horsburgh,Faiz Ahmad Khan,Fayez Kheir,Zhiyi Lan,Alfred Lardizabal,Michael Lauzardo,Joan M. Mangan,Suzanne M. Marks,Lindsay McKenna,Dick Menzies,Carole D. Mitnick,Diana M. Nilsen,Farah Parvez,Charles A. Peloquin,Ann Raftery,H. Simon Schaaf,Neha Shah,Jeffrey R. Starke,John W. Wilson,Jonathan M. Wortham,Terence Chorba,Barbara Seaworth +34 more
TL;DR: New recommendations are made for the choice and number of drugs in a regimen, the duration of intensive and continuation phases, and the role of injectable drugs for MDR-TB.
Journal ArticleDOI
Interferon-γ Release Assays for Active Pulmonary Tuberculosis Diagnosis in Adults in Low- and Middle-Income Countries: Systematic Review and Meta-analysis
John Z. Metcalfe,Charles K. Everett,Karen R Steingart,Adithya Cattamanchi,Adithya Cattamanchi,Laurence Huang,Philip C. Hopewell,Philip C. Hopewell,Madhukar Pai +8 more
TL;DR: In low- and middle-income countries, neither the tuberculin skin test nor IGRAs have value for active tuberculosis diagnosis in adults, especially in the context of HIV coinfection.